Literature DB >> 2541154

A reverse passive haemagglutination test for detection of Japanese encephalitis virus antigens in cerebrospinal fluid.

V Ravi1, S Premkumar, A Chandramuki, J Kimura-Kuroda.   

Abstract

A rapid sensitive and specific reverse passive haemagglutination test (RPHA) was developed for the detection of Japanese encephalitis virus (JEV) antigens in human cerebrospinal fluid (CSF). Sheep red cells were sensitized with five monoclonal antibodies (109, 112, 203, 204 and 301) reactive with envelope glycoprotein of JEV. Viral antigens were detected in CSF from 35 of 58 (60%) clinical cases of JE when the five MAb coated cells were used in combination. An IgM capture ELISA detected JEV specific antibodies in CSF among 52 of these 58 cases (90%). While 29 specimens contained both antigen and IgM antibodies, 23 had only IgM antibodies and 6 had only antigen. RPHA proved valuable for detection of viral antigens in CSF samples obtained within 10 days after onset of clinical symptoms. Amongst the five MAbs used, the individual antigen detection rates were 44, 12, 43, 12 and 36%, for MAbs 109, 112, 203, 204 and 301, respectively.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2541154     DOI: 10.1016/0166-0934(89)90161-4

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  3 in total

Review 1.  Japanese viral encephalitis.

Authors:  S V Tiroumourougane; P Raghava; S Srinivasan
Journal:  Postgrad Med J       Date:  2002-04       Impact factor: 2.401

2.  Japanese encephalitis virus antigen in the human brain and its topographic distribution.

Authors:  A Desai; S K Shankar; V Ravi; A Chandramuki; M Gourie-Devi
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

3.  A need to raise the bar - A systematic review of temporal trends in diagnostics for Japanese encephalitis virus infection, and perspectives for future research.

Authors:  Tehmina Bharucha; Freya M Shearer; Manivanh Vongsouvath; Mayfong Mayxay; Xavier de Lamballerie; Paul N Newton; Nicole Zitzmann; Ernest Gould; Audrey Dubot-Pérès
Journal:  Int J Infect Dis       Date:  2020-03-20       Impact factor: 3.623

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.